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| INTRODUCTION
Animal models have led to the discovery of new strategies for cardiovascular protection and the prevention and management of thrombosis. However, no single model can accurately recapitulate human vascular disease and therefore a range of different arterial thrombosis models have been developed. It has been reported that the same mice and same model in different laboratories have yielded different results, 1 which has been attributed to differences in the surgical techniques utilized rather than the models themselves.
1 Accordingly, it is advocated that the model of thrombosis be carefully selected to answer the research question. 2 Topical application of FeCl 3 on a vessel causes oxidative damage to and aggregation of red blood cells which mediate the adherence of platelets to the non-denuded endothelium. 3, 4 The time to cessation of blood flow can be affected by FeCl 3 concentration, types of anesthesia, as well as surgical techniques. 5 The Folts model is more clinically relevant as it encompasses the combined effects of deep-vessel injury and high-shear stress, thereby mimicking two key elements related to thrombus formation in atherosclerotic vessels. 6, 7 In this model, thrombi are formed and then embolized in repetitive cycles, prior to administration of antithrombotic drugs which abolish these cycles.
6
In the mouse electrolytic model, a thrombus is formed by applying a current to the external surface of the exposed carotid artery during stasis, causing disruption to the endothelial lining of the vessel. Scientific and Standardization Committee (SSC) revealed that overall, the most commonly used murine models of thrombosis are ferricchloride and laser injury followed by mechanical and photochemical injury, then followed by electrolytic injury and other injury methods.
Laser injuries are typically performed as a model of microvascular thrombosis and the site of injury is usually the cremaster and mesenteric arterioles. 2 While this is common, laser injury to the carotid artery to simulate macrovascular thrombosis is seldom performed and therefore has not been included in this study. 1 The same study also documented that type of anesthetic was reported as uncritical, and pentobarbitone and ketamine/xylazine (ket-x) were the most commonly used. 2 However, in countries like Australia pentobarbitone is being reclassified to a Schedule 8 (controlled) drug 8 and is no longer recommended for use as a rodent anesthetic, 9 and moreover, in the United States and many other countries, pentobarbitone is now unavailable. 10 Therefore ket-x and isoflurane are now the anesthetics of choice for laboratory animal experimentation. In rodents low concentrations of isoflurane (<1%) increase systemic blood flow while maintaining cardiac output and myocardial perfusion. Higher isoflurane concentrations (>2.5%) increase peripheral vasodilatation and decrease systemic vascular resistance. 11 Anesthesia with ket-x causes respiratory depression and decreases heart rate and arterial blood pressure; pentobarbitone also causes respiratory depression but does not affect heart rate to the same extent as ket-x.
12
Here, we studied how the three different anesthetics influence the experimental outcomes of the three abovementioned models of arterial thrombosis. The effect of anesthesia on hemodynamics, namely tail bleeding time and platelet aggregation in response to adenosine diphosphate (ADP) and thrombin was also studied. The αIIbβ3 pathway is platelet-specific and mediates several aggregationdependent platelet roles in coagulation, fibrinolysis, etc. and therefore αIIbβ3 antagonists like eptifibatide/integrilin are globally effective in preventing thrombosis. 13 Hence, we examined the efficacy of integrilin in minimizing arterial thrombosis initiated by each mode of injury, with all three anesthetic protocols.
| METHODS

| Animals
Eight-to 10-week-old male C57Bl/6 mice (22-28 g) were used in these studies. Animals were held in the Alfred Medical Research and Education Precinct (AMREP) Animal Services facility, and kept on a 12 h light/dark cycle with ad libitum access to food and water. These studies were approved by the AMREP Animal Ethics Committee (E/1677/2016/M) in accordance with the Australian code for the care and use of animals for scientific purposes 8th edition, 2013.
| Anesthesia
Mice were randomly chosen to be anesthetized with either pentobar- Wales, Australia), or isoflurane (5% for induction and 1.5% for maintenance in 1.0 L/min oxygen; Isothesia, Provet, Heatherton, Victoria, Australia). For ket-x treated animals, a top up dose of 50% of the calculated dose for the animal was administered during the procedure.
Mice were euthanized with an overdose of injectable anesthetic (Lethabarb, Virbac, Milperra, New South Wales, Australia) except for the platelet aggregation experiment-control cohort of mice that were euthanized via CO 2 inhalation.
Essentials
• The Folts, electrolytic and FeCl 3 models of carotid artery clot induction were studied.
• Mice were placed under pentobarbitone, ketamine-xylazine, or isoflurane anesthesia.
• Clotting times and clot stability were variably affected by anesthesia in each model.
• Efficacy of eptifibatide in each model was altered by anesthesia.
| Surgical set-up
In mice receiving injectable anesthetics, a tracheotomy was performed and mice were mechanically ventilated with room air via a respiratory pump (MiniVent Type 845, Hugo Sachs Elektronik, Harvard Apparatus GmbH, March-Hugstetten, Germany) and core body temperature was maintained at 37°C using a heat lamp. The left carotid artery was exposed via blunt dissection, and carefully dissected clear of the vagus nerve and surrounding tissue. A calibrated flow probe (0.5 mm in diameter) linked to a flow meter (TS420, Transonic Systems, Inc., Ithaca, NY, USA) was placed around the artery to measure blood flow velocity (mL/min), which was then corrected for body weight (mL/min/100 g). Blood flow data were acquired using a Powerlab device and analyzed using LabChart Pro., 
| Folts model
This was performed as published. 
| Electrolytic model
Distal to the flow probe, a hook-shaped electrode was placed around the left carotid artery. Integrilin (4 or 10 mg/kg) was administered 10 minutes before electrolytic injury. The artery was then clamped distally to the electrode using hemostatic clamps to occlude blood flow and a current (18-22 mA) was delivered for a set period (2-3 minutes) via the electrode using a lesion making 
| Ferric chloride model
This method was carried out as described. 15 Integrilin ( 
| Carstairs staining
Approximately 3-4 mm of the common carotid artery spanning the site of injury was dissected and stored in 4% phosphate buffered formalin and later processed, paraffin-embedded, and 4-μm thick sections were stained using the Carstairs stain, as described). 4 Staining was performed by the Monash Histology Platform (Clayton, Australia). Using this staining technique, fibrin appears red, platelets appear blue/purple, red blood cells appear yellow, and collagen staining in the vessel wall appears blue. Images were visualized using an Olympus BX50 microscope and a 20X/0.46 NA objective, and the images were captured using an Olympus DP71 digital camera (Olympus, Tokyo, Japan). Image quantification is described in Supporting Information.
| Statistical methods
Data are presented as mean ± SEM. GraphPad Prism version 7.00
for Windows, GraphPad Software, La Jolla, California, USA (www.
graphpad.com) was used for all analyses. Outliers were excluded based on the GraphPad Prism Robust regression and Outlier removal method. Basal blood flow as a function of time was analyzed using a two-way repeated measures ANOVA with Tukey's post-hoc analysis. Comparisons between the three different anesthesia groups were made using one-way ANOVA followed by Tukey's multiple comparisons test. The effect of integrilin treatment was compared with a two-way ANOVA with Tukey's post-hoc analysis for multiple comparisons; for the Folt's model this was done using two-way RM ANOVA with Sidak's post-hoc correction. Histology data was assessed using one-way ANOVA with Tukey's post-hoc analysis and % fibrin area was assessed using Kruskal-Wallis ANOVA with uncorrected Dunn's post-hoc correction. In all cases, statistical significance was accepted if P < 0.05.
| RESULTS
We first assessed whether anesthesia affects blood flow in the carotid artery. Pentobarbitone anesthesia reduced basal blood flow velocity (1.09 ± 0.01 mL/min/100 g) in the carotid artery when compared to ket-x and isoflurane-treated animals. In mice anesthetized with isoflurane pre-experimental basal blood flow was 3.5 times higher than that of pentobarbitone treated mice ( Figure 1A ; n = 6 per group). Therefore, blood flow velocity in the carotid artery ranges from lowest to highest when mice are anesthetized with pentobarbitone, ket-x and isoflurane, respectively.
Next we studied how these changes in blood flow would affect the onset of CFR in the Folts model of mechanical injury. As seen in Figure 1Bi , blood flow had to be reduced to only 64.3 ± 8.1%
of original flow rate to elicit ≥4 CFR in a 10-minute period in mice anesthetized with pentobarbitone. In contrast, in ket-x-injected animals, flow rate had to be reduced to 41.2 ± 11.65% and a similar degree of restriction in flow was required to achieve periodic CFR in isoflurane-treated mice (48.5%; n = 6 per group). Mice anesthetized with pentobarbitone and ket-x show a greater number of cycles (~2x) within a 10-minute period when compared to isoflurane (Figure 1Bii ; n = 6 per group). Mice that were operated under inhaled isoflurane had significantly higher mean blood flow volume F I G U R E 1 Folts model. (A) Basal blood flow in the carotid artery is significantly higher when mice are anesthetized with isoflurane and ket-x than compared to pentobarbitone (n = 6). (B) Greater degree of blood flow restriction is necessary to initiate recurrent cycles of thrombus formation and embolism when mice are placed under anesthesia with ket-x and isoflurane, compared to pentobarbitone (n = 5-6).
(ii) Significantly fewer cycles per 10 min are seen in the isoflurane group. (C) (i) Area under the curve analysis shows that blood flow over an average of three cycles is correspondingly increased in isoflurane-treated animals as validated in (ii) a representative blood flow chart from one animal per cohort (representative of n = 12 animals). Data is mean ± SEM. *P < 0.05; **P < 0.01; ****P < 0.001 (oneway analysis of variance (ANOVA) with Tukey post-hoc analysis) K e t -x I s o f l u r a n e Isoflurane P e n t o b a r b i t o n e K e t -x I s o f l u r a n e P e n t o b a r b i t o n e K e t -x I s o f l u r a n e P e n t o b a r b i t o n e Electrolytic injury resulted in consistent occlusion times only in mice that were anesthetized with pentobarbitone. In fact, application of 18 mA current to the carotid artery had virtually no effect when mice were anesthetized with ket-x and variable effect with isoflurane ( Figure 2Ai ). Accordingly, while stable occlusions were induced in a majority of pentobarbitone-treated mice, only unstable occlusions, if any, were seen when the same current was applied to the carotid arteries of mice anesthetized with ket-x and isoflurane ( Figure 2Aii ).
Hence it was necessary to increase the injury severity by applying a current of 22 mA to the vessel in mice treated with ket-x, as below.
The occlusion times in the isoflurane-treated cohort were still highly variable, with unstable thrombi evident in all mice even when the current was increased 26 and 28 mA ( Figure S1 ; n = 3-5 per group). In fact, even an injury induced at 28 mA current did not yield reproducible occlusive thrombi in isoflurane-treated mice ( Figure S1 ); in some instances, the vessel burst and in other instances unstable occlusions were seen (data not shown). Hence we discontinued electrolytic injury experiments in this cohort and concluded that isoflurane is a not a reliable anesthetic in this paradigm. Isoflurane K e t -x I s o f l u r a n e P e n t o b a r b i t o n e K e t -x I s o f l u r a n e P e n t o b a r b i t o n e K e t -x I s o f l u r a n e P e n t o b a r b i t o n e K e t -x I s o f l u r a n e is only effective at preventing vessel occlusion under pentobarbitone, and ket-x to a lesser degree. Dose of 10 mg/kg is effective in ket-x treated animals and in isoflurane-treated animals, even a dose of 20 mg/kg only resolves thrombi in three out of six animals. Bars are median occlusion time (ii) area under curve show similar trends in that integrilin treatment mitigates arterial thrombosis in mice placed under pentobarbitone at a lower dose and in ket-x anesthesia at 10 mg/kg but not isoflurane even at higher doses of 20 mg/kg. Data is mean ± SEM. (iii) Stable occlusive thrombi are resolved when integrilin is administered in mice that were anesthetized with pentobarbitone and in 50% and 87% of mice treated with ket-x and doses of 4 and 10 mg/kg, respectively but in mice anesthetized with isoflurane even at doses of 20 mg/kg only 50% of mice showed thrombus dissolution (n = 5-6). *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001 (two-way ANOVA with Sidak post-hoc analysis). Second integrilin dataset: dose is 10 mg/kg for ket-x and 20 mg/kg for isoflurane 
| DISCUSSION
Carotid artery injury models have regular variations in severity, clot composition, and clot size and it is widely accepted that the results of a particular anti-thrombotic drug being developed are model dependent. 17 But here we show that the choice of anesthesia also needs to be carefully considered when testing new compounds for treatment of atherothrombosis.
Consistent with our findings, isoflurane is known to increase systemic blood flow but it does not increase blood pressure or cardiac output. 18 Mice anesthetized with 100 mg/kg ket-x have significantly lower heart rates and cardiac output than those treated with isoflurane, 19 possibly due to peripheral α2-adrenoceptor blockade. 18 This may explain why ket-x treated animals had lower basal blood flow velocities. We found that carotid artery basal blood flow was slowest under pentobarbitone anesthesia. This may be explained by earlier reports showing that pentobarbitone does not alter heart rate but reduces the cardiac index in mice due to a direct negative inotropic action on the myocardium or by inhibition of cardiac sympathetic tone. 18 Shear rate is a function of velocity and is inversely proportional to vessel diameter.
20
Isoflurane and ket-x increase basal blood flow velocities but also appear to increase vessel diameter in our study, while pentobar- 
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In a rabbit model of Folts-like arterial stenosis, anesthesia using either pentobarbitone or isoflurane did not alter the number of CFR observed over a 45-minute period. 21 In our hands, to initiate regular CFR under anesthesia with both ket-x and isoflurane, a higher degree of blood flow restriction was required. It should be noted that the percent reduction in blood flow in each cohort was not directly proportional to the basal blood flow, indicating that the blood flow rate for successful CFR induction under each anesthetic method is not merely a factor of basal blood flow rate. Once comparable CFR were initiated, there was a greater volume of blood flow in the isofluranetreated mice, which would promote the washout of clotting factors thereby justifying the reduced numbers of CFR noted in mice anesthetized with isoflurane and subjected to Folts-stenosis injury.
22
Multiple studies have shown that isoflurane has complex vasomotor effects. 16, 18, 23 We attribute the lack of success of the electrolytic injury in formation of reproducible thrombi under isoflurane anesthesia to the observed physical changes in the vessel caused by this agent.
Indeed the histological data strengthens the case that isoflurane results in the thinning of the vessel wall which could explain the increased risk of the vessel bursting under isoflurane in our experiments.
The FeCl 3 thrombosis model although convenient, is not clinically relevant, as the endothelium is not denuded by application of FeCl 3.
4
Isoflurane appears to exert both pro-dilatory and pro-constrictive vasomotor properties. While it reduces endothelium-mediated vessel dilatation by attenuating secretion of nitric oxide, when endothelial denudation occurs, such as during mechanical injury, this effect is lost and vasodilatation is increased in denuded vessels. 23 Thus, future experiments should involve histological assessment of the carotid artery specimens of mice that have been subjected to electrolytic injury or Folts preparation to determine whether the vessels are more dilated under isoflurane anesthesia in these models.
The sensitivity to FeCl 3 concentration is based on its intraluminal mass transport, which in turn is a function of blood velocity and vessel diameter both of which are increased under ket-x and isoflurane
anesthesia. Yet curiously application of 6% FeCl 3 did not trigger the formation of stable occlusive thrombi only in the ket-x treated group. This is similar to the electrolytic injury wherein a greater current had to be applied to initiate thrombus formation in the ket-x treated group when compared to the pentobarbitone treated group.
Preventing the interaction of activated αIIbβ3 with its ligands represents the final common pathway for platelet aggregation and underpins our choice of integrilin in this study. 24 kg is 100-fold higher than the prescribed bolus dose in humans.
Taken together with the finding that doses of up to 10 mg/kg were sufficient to achieve thrombus resolution in all paradigms barring the isoflurane-treated mice under FeCl 3 injury it stands to reason that the specific differences in efficacy of this drug are due to the anesthetic protocol and not the administered dose. Eptifibatide is a cyclic heptapeptide that competitively blocks the interaction of fibrinogen and the RGD binding site on integrin. Species differences in the ligand binding region of αIIbβ3 render rodent platelets less responsive to inhibition with RGD-based compounds. 32 Overall, the variability in efficacy of integrilin in the three models shows that the same anti-thrombotic drug can elicit different effects simply by changing the anesthetic protocol. Further, within each of these models, anesthetics alter the efficacy of integrilin.
Here we present a comprehensive study wherein three anesthetic protocols have been compared under the same experimental conditions, from a single source of C57Bl6 wildtype mice, and by a single operator. The findings in our study raise the important question as to how many potentially efficacious antithrombotic drugs are disregarded in in vivo models owing to the choice of model and anesthesia
protocol.
